European Journal of Internal Medicine

Papers
(The TQCC of European Journal of Internal Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection925
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study316
Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis302
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)282
Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia204
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease155
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy144
Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data129
Electrocardiographic features of patients with COVID-19 pneumonia103
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.101
SARS-CoV-2 vaccines: Lights and shadows91
Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort90
Hepatic consequences of COVID-19 infection. Lapping or biting?80
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study64
Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler61
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.60
Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era59
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study54
The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations52
Uric acid in metabolic syndrome: Does uric acid have a definitive role?52
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease51
Low serum albumin: A neglected predictor in patients with cardiovascular disease50
Mechanisms of weight regain.49
Optimizing antibiotic therapies to reduce the risk of bacterial resistance49
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors48
The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions44
SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade44
Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?43
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series41
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later40
Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries40
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology39
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine38
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations37
Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis35
Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration35
ANCA associated vasculitis34
Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management34
Management of hyperuricemia in asymptomatic patients: A critical appraisal34
How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity32
Pneumothorax/pneumomediastinum in non-intubated COVID-19 patients: Differences between first and second Italian pandemic wave32
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery32
COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect"32
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis31
Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review.30
Therapeutic strategies for virus-negative myocarditis: a comprehensive review30
Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroente29
Comparison of bias and accuracy using cystatin C and creatinine in CKD-EPI equations for GFR estimation28
Assessing the impact of COVID-19 on the health of geriatric patients: The European GeroCovid Observational Study28
Acidosis predicts mortality independently from hyperlactatemia in patients with sepsis27
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations27
Seventeen-year trend (2001–2017) in pacemaker and implantable cardioverter-defibrillator utilization based on hospital discharge database data: An analysis by age groups27
Left atrial diameter thresholds and new incident atrial fibrillation in embolic stroke of undetermined source27
Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis26
Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review26
The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus–related hepatocellular carcinoma26
Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach25
NAFLD and autoimmune hepatitis: Do not judge a book by its cover25
kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers25
Obesity as an adipose tissue dysfunction disease and a risk factor for infections – Covid-19 as a case study25
Physical decline and cognitive impairment in frail hypertensive elders during COVID-1925
Physical activity in management of persons with obesity24
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-1924
Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence.24
Effect of SGLT-2 inhibitors on cardiovascular outcomes in heart failure patients: A meta-analysis of randomized controlled trials24
Monkeypox infection: An update for the practicing physician23
Management of chronic refractory cough in adults23
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad?22
A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry22
COVID-19 vaccination and a severe pain in the neck22
ChAdOx1 nCoV-19 effectiveness during an unprecedented surge in SARS COV-2 infections22
The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated22
The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency22
No double-edged sword and no doubt about the relation between smoking and COVID-19 severity21
Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome21
The impact of nutrition and lifestyle modification on health21
Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study21
Active smoking and COVID-19: a double-edged sword21
Serum IgG4 level predicts COVID-19 related mortality21
Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)21
Is low sodium intake a risk factor for severe and fatal COVID-19 infection?21
Recent advances in pericarditis20
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study20
Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor20
Both lean and fat body mass associate with blood pressure20
Efficacy and safety of molnupiravir for COVID-19 patients20
Inhaled long-acting muscarinic antagonists in asthma – A narrative review20
Uric acid associated with acute heart failure presentation in Acute Coronary Syndrome patients20
Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey19
Obesity and sleep disturbances: The “chicken or the egg” question19
Clinical phenotypes and prediction of chronicity in sarcoidosis using cluster analysis in a prospective cohort of 694 patients19
Acute kidney injury associated with non-steroidal anti-inflammatory drugs19
Patient motivation to lose weight: Importance of healthcare professional support, goals and self-efficacy19
Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study19
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases19
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights18
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study18
Long term clinical outcomes in survivors after out-of-hospital cardiac arrest18
Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines18
Associations of Post-Acute COVID syndrome with physiological and clinical measures 10 months after hospitalization in patients of the first wave18
Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-1918
Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry18
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis18
Sarcopenia measurement in research and clinical practice18
Knowing the new Omicron BA.2.75 variant (‘Centaurus’): A simulation study18
Admission glucose level was associated with increased short-term mortality and length-of-stay irrespective of diagnosis, treating medical specialty or concomitant laboratory values18
Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence?17
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection17
Serum uric acid and mortality thresholds among men and women in the Irish health system: A cohort study17
Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study17
Treat-to-target in systemic lupus erythematosus: Where are we?17
Prevalence and impact on outcome of sodium and potassium disorders in patients with community-acquired pneumonia: A retrospective analysis17
Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety17
Chronic cough in adults17
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy17
A new simplified model for predicting 30-day mortality in older medical emergency department patients: The rise up score17
Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.17
“Let me choose my COVID-19 vaccine”16
THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS.16
COVID-19: Timing is Important16
Predictors of mortality of influenza virus infections in a Swiss Hospital during four influenza seasons: Role of quick sequential organ failure assessment16
Erectile dysfunction and adherence to antihypertensive therapy: Focus on β-blockers16
Management and outcomes of post-acute COVID-19 patients in Northern Italy16
Sweet taste and obesity16
The yield of F18 FDG PET-CT for the investigation of fever of unknown origin, compared with diagnostic CT16
The use of β-blockers in patients with heart failure and comorbidities: Doubts, certainties and unsolved issues16
Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury16
Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives15
Identification of chronic thromboembolic pulmonary hypertension on CTPAs performed for diagnosing acute pulmonary embolism depending on level of expertise15
Hypernatremia and moderate-to-severe hyponatremia are independent predictors of mortality in septic patients at emergency department presentation: A sub-group analysis of the need-speed trial15
The coupling between sarcopenia and COVID-19 is the real problem15
Identification and management of acute alcohol intoxication15
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis15
Lung ultrasonography: A prognostic tool in non-ICU hospitalized patients with COVID-19 pneumonia15
The challenge of implementing Less is More medicine: A European perspective15
The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination15
The association between education level and chronic liver disease of any etiology15
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation 15
Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors15
Venous thromboembolism during pregnancy and postpartum period15
Coffee Consumption is Associated with a Decreased Risk of Incident Chronic Kidney Disease: A Systematic Review and Meta-analysis of Cohort Studies15
Future directions in obesity pharmacotherapy15
Hyperhomocysteinemia in patients with acute porphyrias: a possible effect of ALAS1 modulation by siRNAm therapy and its control by vitamin supplementation15
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis14
Prevalence and risk factors for pulmonary embolism in patients with suspected acute exacerbation of COPD: a multi-center study.14
Longitudinal changes of left and right cardiac structure and function in patients with end-stage renal disease on replacement therapy14
Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism14
Timeline analysis of clinical severity of COVID-19 in the general population14
Alcohol consumption and risk of incident atrial fibrillation: A population-based cohort study14
Covid-19 in Italy: Lesson from the Veneto Region14
Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention14
Metabolically healthy obesity: Misleading phrase or healthy phenotype?14
Early osteopontin levels predict mortality in patients with septic shock14
Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-1914
Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation14
Sympathetic activation and outcomes in chronic heart failure: Does the neurohormonal hypothesis apply to mid-range and preserved ejection fraction patients?14
Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?14
Atrial cardiomyopathy markers and new-onset atrial fibrillation risk in patients with acute myocardial infarction13
Non-HACEK gram negative bacilli endocarditis: Analysis of a national prospective cohort.13
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy13
Impact of point of care ultrasound on the number of diagnostic examinations in elderly patients admitted to an internal medicine ward13
Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes13
High prevalence of malnutrition in Internal Medicine wards – a multicentre ANUMEDI study13
Blood pressure increase during hospitalization for COVID-1913
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression13
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre13
COVID-19 randomized controlled trials in medRxiv and PubMed13
Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: The Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF13
Effects of non-invasive respiratory supports on inspiratory effort in moderate-severe COVID-19 patients. A randomized physiological study13
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study13
Validation of the AF-ESUS score to identify patients with embolic stroke of undetermined source and low risk of device-detected atrial fibrillation12
Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry12
Active smoking and severity of coronavirus disease 2019 (COVID-19): The use of significance testing leads to an erroneous conclusion12
The link between nutritional status and outcomes in COVID-19 patients in ICU: Is obesity or sarcopenia the real problem?12
A systematic review of the discrimination and absolute mortality predicted by the National Early Warning Scores according to different cut-off values and prediction windows12
Embolic risk stratification and prognostic impact of early surgery in left-sided infective endocarditis12
Why optional inferior vena cava filters are not always retrieved? A real world 19 years experience in a Swiss tertiary care university hospital.12
Quality of care after AKI development in the hospital: Consensus from the 22nd Acute Disease Quality Initiative (ADQI) conference12
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B12
Prevalence of markers of atrial cardiomyopathy in embolic stroke of undetermined source: A systematic review12
Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis12
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group12
Mild to moderate hyponatremia at discharge is associated with increased risk of recurrence in patients with community-acquired pneumonia12
Waste in COVID-19 clinical trials conducted in western Europe12
Pre-operative physical performance as a predictor of in-hospital outcomes in older patients undergoing elective cardiac surgery12
Refining age stratum of the C2HEST score for predicting incident atrial fibrillation in a hospital-based Chinese population12
Autologous fecal microbiota transplantation can retain the metabolic achievements of dietary interventions12
The COVID-19 burden for health care professionals: Results of a global survey12
Efficacy and safety of steroid-sparing treatments in giant cell arteritis according to the glucocorticoids tapering regimen: A systematic review and meta-analysis12
Thrombocytopenia in primary antiphospholipid syndrome, a marker of high-risk patients?12
Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure11
Low Creatinine Potentially Overestimates Glomerular Filtration Rate in Older Fracture Patients: A Plea for an Extensive Use of Cystatin C?11
Alcoholic liver disease and autoimmune hepatitis: Sometimes a closer look under the surface is needed11
Light anti-thrombotic regimen for prevention of device thrombosis and/or thrombotic complications after interatrial shunts device-based closure11
Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation?11
Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program11
Pulmonary embolism severity and in-hospital mortality: An international comparative study between COVID-19 and non-COVID patients11
Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: The RA-HF study11
Sex-specific outcomes and management in critically ill septic patients11
Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver11
Exploring the recovery curve for long-term post-COVID dyspnea and fatigue11
Definition of tachycardia for risk stratification of pulmonary embolism11
Effectiveness of telemedicine in patients with heart failure according to frailty phenotypes: Insights from the iCOR randomised controlled trial11
Multidisciplinary prevention and management strategies for colorectal cancer and cardiovascular disease10
Predictors of infection after “de novo” cardiac electronic device implantation10
Gender gap in authorship: a study of 44,000 articles published in 100 high-impact general medical journals10
Infective endocarditis in patients with solid organ transplantation. A nationwide descriptive study10
Why should we use convalescent plasma for COVID-19?10
Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study10
Colchicine – new horizons for an ancient drug. Review based on the highest hierarchy of evidence10
Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis10
Diagnostic accuracy of D-Dimer testing for recurrent venous thromboembolism: A systematic review with meta-analysis.10
Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases10
SARS-CoV-2 vaccine-induced cerebral venous thrombosis10
De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?10
Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials10
Long-term recurrence risk after a first venous thromboembolism in men and women under 50 years old: A French prospective cohort10
COVID-19 and hydroxychloroquine: Is the wonder drug failing?10
Thrombotic events following Covid-19 vaccines compared to Influenza vaccines10
POCUS in dyspnea, nontraumatic hypotension, and shock; a systematic review of existing evidence10
Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillation10
Statins and inflammatory bowel disease: Where do we stand?10
Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis10
The ISTH DIC score predicts outcome in non-septic patients admitted to a cardiovascular intensive care unit10
Hyperglycemia drives the transition from pre-frailty to frailty: The Monteforte study10
The effect of sodium-glucose cotransporter-2 inhibitors on cardiac structure remodeling and function: A meta-analysis of randomized controlled trials10
Cardiopulmonary exercise test with stress echocardiography in COVID-19 survivors at 6 months follow-up10
Point of care ultrasound for rapid assessment and treatment of palliative care patients in acute medical settings10
Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE10
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of10
Effects of Anti-vitamin k oral anticoagulants on bone and cardiovascular health10
Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up10
How many urinalysis and urine cultures are necessary?9
Optimization of antimicrobial prescription in the hospital9
Atrial fibrillation in patients with inflammatory bowel disease: A systematic review and meta-analysis9
Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic9
Impact of pre-hospital renal function on the detection of acute kidney injury in acute decompensated heart failure9
Potential mechanisms of vaccine-induced thrombosis9
Reduced COVID-19 mortality linked with early antibodies against SARS-CoV-2, irrespective of age9
Long-term effectiveness and safety of anticoagulation therapy in oldest old, frail people with atrial fibrillation9
Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program9
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations9
Gender distribution in boards of internal medicine societies9
Sustainable and personalized nutrition: From earth health to public health9
Severe acute respiratory syndrome coronavirus 2 evolution: How mutations affect XBB.1.5 variant9
Temporal changes in co-morbidities and mortality in patients hospitalized for COVID-19 in Italy9
Exploring the possible link between myocarditis and mRNA COVID-19 vaccines9
Neuraminidase inhibitors are effective and safe in reducing influenza complications: meta-analysis of randomized controlled trials.9
Long term consequences of COVID-199
Is the 2020 Sampson equation the best formula for LDL-C estimation?9
0.06515908241272